Search PDMR transactions

Notifier
Name of person with notification obligation
Petrus Lindh
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
Petrus Lindh
Position
Other member of the company's administrative, management or supervisory body
Initial notification
No
Amendment
Yes
Details of amendment
LEI-kod
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Hansa Biopharma AB
Issuer’s LEI code
549300LLEO25ZJJ3NT91
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share HANSA BIOPHARMA SE0002148817 Acquisition 300 Quantity 185.70 SEK 19/01/2021 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
HANSA BIOPHARMA SE0002148817 Acquisition 19/01/2021 NASDAQ STOCKHOLM AB 300 (Quantity) 185.70 SEK
<< Back